Short interest screen · refreshed after the Nov 9, 2026 close
Highest days to cover: Healthcare
Short positions that would take the longest to unwind at normal trading volume. Days to cover divides the shares sold short by average daily volume. A higher number means short sellers would need more time to buy back shares, which can make a rally sharper.
| # | Company | Price | Today | Days to cover | Short % float | Δ short int. | Mkt cap |
|---|---|---|---|---|---|---|---|
| 101 | DNTHDianthus TherapeuticsHealthcare | $90.37 | +5.04% | 10.2 | 18.4% | −2% | $5.09B |
| 102 | ANIPANI PharmaceuticalsHealthcare | $68.28 | +1.28% | 10.1 | 18.1% | −1% | $1.55B |
| 103 | MAZEMaze TherapeuticsHealthcare | $34.85 | +1.93% | 10.1 | 18.8% | +15% | $1.94B |
| 104 | RZLTRezolute, Inc. Common Stock (NV)Healthcare | $4.16 | +7.09% | 10.1 | 22.5% | +15% | $401.9M |
| 105 | BNTCBenitec BiopharmaHealthcare | $9.54 | −0.05% | 10.1 | 9.4% | −2% | $332.7M |
| 106 | CAMPCAMP4 TherapeuticsHealthcare | $4.53 | +11.45% | 10.1 | 8.2% | +136% | $284.0M |
| 107 | LXEOLexeo TherapeuticsHealthcare | $3.17 | +8.56% | 10.0 | 22.9% | −9% | $260.2M |
| 108 | KYMRKymera TherapeuticsHealthcare | $136.79 | +3.84% | 10.0 | 13.7% | −7% | $11.68B |
| 109 | AMLXAmylyx PharmaceuticalsHealthcare | $30.11 | +2.07% | 9.9 | 13.7% | +5% | $3.87B |
| 110 | TMDXTransMedics GroupHealthcare | $93.41 | +5.86% | 9.9 | 27.3% | +3% | $3.24B |
| 111 | AMPHAmphastar PharmaceuticalsHealthcare | $29.30 | +2.83% | 9.9 | 14.9% | −2% | $1.25B |
| 112 | PVLAPalvella TherapeuticsHealthcare | $174.60 | −0.75% | 9.8 | 21.7% | −5% | $2.55B |
| 113 | ARQTArcutis BiotherapeuticsHealthcare | $25.30 | −0.98% | 9.8 | 18.0% | −6% | $3.20B |
| 114 | ESTAEstablishment Labs HoldingsHealthcare | $67.34 | +0.48% | 9.8 | 16.7% | +1% | $2.01B |
| 115 | OBIOOrchestra BioMed HoldingsHealthcare | $5.76 | +1.41% | 9.7 | 8.1% | 0% | $354.0M |
| 116 | RCUSArcus BiosciencesHealthcare | $18.79 | +2.79% | 9.7 | 13.6% | −6% | $2.71B |
| 117 | EYENational Vision HoldingsHealthcare | $19.13 | +6.87% | 9.7 | 20.4% | +1% | $1.51B |
| 118 | NUVBNuvation BioHealthcare | $4.29 | +3.00% | 9.7 | 23.9% | +7% | $1.51B |
| 119 | CGONCG OncologyHealthcare | $74.26 | −2.28% | 9.7 | 12.9% | −15% | $6.58B |
| 120 | DVADaVitaHealthcare | $187.11 | −2.22% | 9.7 | 7.9% | −5% | $11.77B |
| 121 | KRROKorro BioHealthcare | $15.39 | +4.34% | 9.6 | 14.8% | +3% | $226.6M |
| 122 | VCELVericelHealthcare | $58.53 | +7.16% | 9.5 | 11.1% | +1% | $2.99B |
| 123 | PBLSParabilis MedicinesHealthcare | $29.88 | +4.73% | 9.5 | 9.1% | +12% | $3.69B |
| 124 | STIMNeuroneticsHealthcare | $2.38 | +10.47% | 9.4 | 20.3% | +2% | $184.6M |
| 125 | CERSCerusHealthcare | $2.03 | +0.25% | 9.4 | 8.6% | −5% | $409.0M |
| 126 | DTILPrecision BioSciencesHealthcare | $10.30 | −2.88% | 9.4 | 9.1% | −6% | $287.6M |
| 127 | NRIXNurix TherapeuticsHealthcare | $16.63 | +8.69% | 9.2 | 21.0% | +17% | $1.82B |
| 128 | BHVNBiohavenHealthcare | $15.31 | +5.73% | 9.2 | 14.9% | −6% | $2.31B |
| 129 | XNCRXencorHealthcare | $39.29 | +9.90% | 9.1 | 17.0% | −25% | $2.95B |
| 130 | ALKSAlkermesHealthcare | $47.04 | +2.48% | 9.1 | 11.5% | +7% | $7.90B |
| 131 | MDXGMiMedx GroupHealthcare | $3.35 | +1.06% | 9.1 | 8.1% | −1% | $488.1M |
| 132 | PRGOPERRIGOHealthcare | $16.57 | +4.54% | 9.0 | 17.5% | 0% | $2.30B |
| 133 | EBSEmergent BiosolutionsHealthcare | $6.18 | +1.98% | 9.0 | 19.3% | +4% | $317.7M |
| 134 | VORVor BiopharmaHealthcare | $20.46 | +2.92% | 9.0 | 17.6% | −5% | $1.26B |
| 135 | AUPHAurinia PharmaceuticalsHealthcare | $16.52 | +0.36% | 9.0 | 7.3% | −2% | $2.21B |
| 136 | LRMRLarimar TherapeuticsHealthcare | $2.47 | +3.35% | 9.0 | 23.8% | −5% | $256.6M |
| 137 | BVSBioventusHealthcare | $11.02 | +3.82% | 9.0 | 8.2% | +1% | $754.2M |
| 138 | COGTCogent BiosciencesHealthcare | $33.32 | +5.29% | 8.9 | 13.2% | +1% | $5.78B |
| 139 | NHCNational HealthcareHealthcare | $212.55 | +1.77% | 8.9 | 6.1% | −8% | $3.33B |
| 140 | WGSGeneDx HoldingsHealthcare | $62.28 | −0.14% | 8.7 | 32.1% | +7% | $1.86B |
| 141 | CYTKCytokineticsHealthcare | $54.83 | +2.12% | 8.7 | 15.4% | −4% | $7.64B |
| 142 | UFPTUFP TechnologiesHealthcare | $320.14 | +5.49% | 8.7 | 13.3% | −5% | $2.48B |
| 143 | ENOVEnovisHealthcare | $27.97 | +2.96% | 8.7 | 20.9% | +11% | $1.61B |
| 144 | SIBNSI-BONEHealthcare | $25.37 | +4.66% | 8.7 | 10.9% | −8% | $1.14B |
| 145 | OGNOrganon &Healthcare | $13.86 | −0.05% | 8.6 | 7.2% | −1% | $3.64B |
| 146 | TRDAEntrada TherapeuticsHealthcare | $4.76 | −2.76% | 8.6 | 13.0% | +9% | $186.2M |
| 147 | KURAKura OncologyHealthcare | $7.58 | +4.26% | 8.6 | 18.3% | −1% | $674.3M |
| 148 | ENTAEnanta PharmaceuticalsHealthcare | $11.47 | +4.27% | 8.6 | 8.2% | −11% | $334.1M |
| 149 | ARMPArmata PharmaceuticalsHealthcare | $3.68 | +4.70% | 8.5 | 4.4% | −7% | $136.6M |
| 150 | RLMDRelmada TherapeuticsHealthcare | $4.17 | +6.79% | 8.5 | 14.0% | −9% | $444.3M |
Data guard: 1 stock withheld — KPLT (float record is implausibly small). They return once the float record is verified.
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.